How To Distinguish Real Moats from Timing Advantages In Technology Due Diligence
- Arise Innovations
- Jul 5
- 3 min read
Most M&A technology due diligence checks whether the technology works.
Almost nobody checks whether the moat holds.
These are not the same question.
The conflation
Deal teams routinely conflate two things that feel similar but are structurally distinct: comprehension difficulty and replicability difficulty.
The technology is hard to understand, therefore it must be hard to replicate.
That inference is wrong more often than it is right. And when it is wrong, the deal prices a moat that does not exist.
The question is not whether the technology is differentiated. It is:
what kind of differentiation you are looking at — and how long it survives a well-resourced competitor.
Some positions are structurally defended — the architecture depends on inputs a competitor cannot access. That kind of advantage degrades slowly, if at all. Other positions are well-executed but architecturally replicable — any competent team with equivalent capital could rebuild the core in 12–24 months. That is a timing advantage, not a moat. Still others are positioned through commercial momentum — integrations, customer relationships, market position — not through the architecture itself.
The word "moat" collapses these into one. That is not simplification. It is a pricing error.
The technology due diligence case
A VC fund evaluating a Series B in an industrial technology platform requested an independent assessment. The target had built a data processing architecture for industrial sensor networks and claimed a 3–5 year replicability barrier.
Strong commercial conviction. Growing TAM. Sticky customers. But the technology claims were commercially opaque — the fund lacked the internal capability to verify whether the architecture was genuinely novel or a well-packaged integration of open-source components.
The core question was binary: Structural moat — or timing advantage?
The decomposition
We broke the system into five functional layers. Mapped each against open-source equivalents and competing implementations. Classified each by defensibility type. Stress-tested each against a funded competitor scenario.
The finding:
3 of 5 layers were replicable using open-source frameworks within 12–18 months.
2 layers — a proprietary protocol translation engine and a sensor-specific data normalization pipeline — represented genuine IP with a 3+ year barrier. But that barrier held only in combination with the target's accumulated training data from 400+ industrial deployments.
The moat was real. It was also narrower than claimed — and structurally dependent on continued data accumulation velocity.
The outcome
The fund proceeded with the investment at a repriced valuation.
Not a killed deal. A repriced deal with full risk transparency. The IC knew exactly what they were buying: genuine IP in two layers, engineering competence in three, and a moat duration contingent on commercial velocity rather than architectural lock-in.
Why this keeps repeating
Every technology-intensive deal — industrial platforms, AI systems, life sciences instruments, advanced materials, cleantech, complex software — carries a version of this question. The technology has multiple layers. Some are genuinely proprietary. Others are engineering competence on available infrastructure.
The deal team's conviction about the technology is almost always built on comprehension difficulty, not on a structured assessment of replicability. That conflation is the failure mode.
It is quiet, it is structural, and it repeats across sectors.
The people closest to the technology — founders, CTOs, deal sponsors — have every incentive to frame engineering competence as proprietary advantage. That is not dishonesty. It is perspective. What they cannot see is whether the difficulty of building it is structural or merely sequential.
An independent assessment exists to answer that question from outside the deal's own conviction.
What follows
If you are pricing a technology-heavy deal, someone in the process needs to decompose the architecture. Not describe it. Decompose it.
Most deal teams do not skip this step because they reject its value. They skip it because no one in the process is assigned to do it.
That is a structural gap. And it has a price. Full article with the case study and references available here:
I help organizations reduce uncertainty by turning complex, fragmented and multi-domain information into independent, evidence-based decision assets.
My work combines market intelligence, technology assessment, competitive analysis and commercialization insights into structured reports that support investment, innovation and growth decisions.
Comments